Exploratory biomarkers to predict the benefit of adding mitomycin (MM) to BCG as intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC)
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined